Surgical treatment in malignant pleural effusion

被引：1
作者：
Karadayi, Sule [1 ]
Sahin, Ekber [1 ]
机构：
[1] Cumhuriyet Univ, Dept Thorac Surg, Med Fac, TR-58140 Sivas, Turkey
来源：
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2021年 / 29卷 / 04期
关键词：
Malignancy; pleural effusion; pleural metastasis; pleurectomy; tunneled pleural catheter; OVARIAN-CANCER; TALC POUDRAGE; LUNG-CANCER; MANAGEMENT; PLEURODESIS; CATHETER; SURVIVAL; CLASSIFICATION; PLEURECTOMY; RESECTION;
D O I：
10.5606/tgkdc.dergisi.2021.20580
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Malignant pleural effusion can be described as the presence of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these patients ranges between 3 and 12 months. Treatment options for malignant pleural effusion vary from observation in asymptomatic patients to pleurectomies or even extrapleural pneumonectomies in severe cases.
引用
收藏
页码：577 / 585
页数：9
相关论文
共 44 条
  • [41] Efficacy and Safety of Tunneled Pleural Catheters in Adults with Malignant Pleural Effusions: A Systematic Review
    Van Meter, Margaret E. M.
    Mckee, Kanako Y.
    Kohlwes, R. Jeffrey
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (01) : 70 - 76
  • [42] Thoracoscopic talc poudrage pleurodesis for malignant effusions - A review of 360 cases
    Viallat, JR
    Rey, F
    Astoul, P
    Boutin, C
    [J]. CHEST, 1996, 110 (06) : 1387 - 1393
  • [43] Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma
    Wright, Cameron D.
    [J]. ANNALS OF THORACIC SURGERY, 2006, 82 (04) : 1234 - 1239
  • [44] Survival of lung adenocarcinoma patients with malignant pleural effusion
    Wu, Shang-Gin
    Yu, Chong-Jen
    Tsar, Meng-Feng
    Liao, Wei-Yu
    Yang, Chih-Hsin
    Jan, I-Shiow
    Yang, Pan-Chyr
    Shin, Jin-Yuan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (06) : 1409 - 1418
12345